Biotech Startups

CGenetix develops liquid biopsy biomarkers using circulating cell-free DNA to detect organ damage, with a focus on transplantation (kidney, lung, pancreas) rejection diagnostics. The company applies techniques such as digital PCR, NGS and bioinformatics to build in vitro diagnostic tests for the medical and clinical community.

1 investor

CHA Biotech is a South Korean biotechnology company operating in areas including cord blood banking, cell insurance, genomics, CDMO manufacturing, and healthcare consulting. It also runs related businesses such as the Chaum health center and IT services.

1 investor

Charité – Universitätsmedizin Berlin is a university hospital in Germany providing the full range of medical care, from emergency and primary care to highly specialized therapies, prevention, and aftercare, alongside medical research. It serves patients in the Berlin and Brandenburg region.

1 investor

CheckMAB develops safer and more effective therapies targeting cancer and autoimmune diseases.

1 investor

Chemical.AI transforms chemical synthesis through artificial intelligence and retrosynthetic analysis, serving pharmaceutical, biotech, and contract research organizations with tools to optimize synthetic routes and accelerate drug discovery.

1 investor

ChemID provides a data management platform that extracts, translates, and centralizes chemical and lab data from multiple file formats, with visualization tools and blockchain-secured storage for laboratories and chemical organizations.

1 investor

ChemoPharma is a solutions platform in Malaysia providing clinical diagnostics, analytical and industrial solutions for oil and gas, and life sciences offerings. The company also delivers laboratory information management systems, project management, and technical support services across the diagnostic and scientific technology value chain.

1 investor

ChemPilot is an AI platform for chemistry that predicts chemical reactions, finds alternative synthetic pathways, and visualizes molecules in 3D. It targets chemists and researchers to support lab work and research.

1 investor

QbDVision develops a Digital CMC (Chemistry, Manufacturing, and Controls) platform that captures structured product and process data to support end-to-end product lifecycle management from R&D through commercial manufacturing. It serves biopharma organizations and CDMOs, providing a validated SaaS environment aligned with FAIR principles and ICH guidelines to accelerate pharmaceutical development and tech transfer.

1 investor

Chi Botanic uses plant cell culture to grow plant compounds and ingredients in a lab without soil or pesticides, producing products such as cell-cultured Aloe vera, vanilla, and citrus. It supplies these sustainably produced plant-based ingredients to industries seeking consistent, high-quality plant compounds.

1 investor

Chiesi is a global pharmaceutical company that develops and distributes medications across multiple therapeutic areas. The company operates through subsidiaries in Europe, Asia, the Americas, and other regions.

1 investor

Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.

1 investor

Chime Biologics is a contract development and manufacturing organization (CDMO) that provides end-to-end support for biologics production, from cell line development through clinical and commercial manufacturing. The company launched the Chime AI Platform, which integrates artificial intelligence into discovery, candidate validation, cell line development, and manufacturing for biopharmaceutical partners.

1 investor

Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.

1 investor

ChromaDex supplies phytochemical reference standards and botanical reference materials used for research, method development, quality control, and regulatory compliance in the natural products industry. Its catalogue of over 2,000 phytochemical standards serves the pharmaceutical, dietary supplement, food, beverage, cosmetic, and life science sectors, and it is now part of the LGC Standards portfolio.

1 investor

ChromaTan develops biomanufacturing solutions that accelerate product development. The company focuses on manufacturing and biotech applications.

1 investor

Chromis Therapeutics is a biotech company with board members experienced in pharmaceutical development, corporate development, and healthcare investments. The board includes executives with extensive backgrounds in drug discovery, licensing, and biotech operations.

1 investor

1 investor

ChucaoTech develops agrotech and bioinnovation solutions. The company is based in Patagonia, Chile and focuses on supporting SMEs through agricultural technology innovation.

1 investor

Cibus develops crops using a proprietary gene-editing technology that reproduces nature's own genetic blueprints to add specific traits, such as resistance to heat, pests, fungus, and weeds. Working with agricultural partners, it aims to breed seeds faster and produce more resilient, sustainable crops that require fewer chemical inputs.

1 investor

CIC is a venture capital firm that invests in and advises entrepreneurs building life sciences and deep tech companies, positioning itself within a science and technology ecosystem. It emphasizes impact and ESG alongside financial returns.

1 investor

CIGA Healthcare is a family-owned manufacturer of rapid diagnostic and self-test medical devices sold under its Suresign brand to pharmacies, health services, and retailers in over 70 countries. It supplies over-the-counter, professional, and veterinary diagnostic tests and runs an R&D program covering digital readers, spectroscopy, and disease testing.

1 investor

CIMA manufactures intraocular lenses (IOLs) and optical devices designed for cataract surgery and vision correction. The company produces IOLs using advanced biocompatible materials with features like aspheric optics, square edges, and blue light filtering for patients undergoing cataract procedures.

1 investor

CimCure develops active cancer vaccines that use its proprietary Immune-Boost (iBoost) technology to prompt the body to produce antibodies that attack and destroy the blood vessels feeding solid tumours, stopping cancer growth. Founded as a spin-off from the Angiogenesis Laboratory at Amsterdam UMC, the biotech company targets all types and stages of solid tumours.

1 investor